Selected article for: "post infection and previous report"

Author: Rizzetto, Giulio; Diotallevi, Federico; Campanati, Anna; Radi, Giulia; Bianchelli, Tommaso; Molinelli, Elisa; Mazzanti, Sara; Offidani, Annamaria
Title: Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience
  • Cord-id: hkn2mjnz
  • Document date: 2020_11_23
  • ID: hkn2mjnz
    Snippet: Telogen effluvium (TE) is one of the most common form of hair loss in women. Many triggers have been identified, as stress, drugs, trauma, endocrine disease, nutritional deficiencies, and febrile states. We report three cases of TE occurred after severe Sars‐Cov‐2 infection and provide our clinical management, according to Sars‐Cov‐2 hygiene measures. Only one case report has been found in the literature associating anagen effluvium during severe Sars‐Cov‐2 infection. Other studies r
    Document: Telogen effluvium (TE) is one of the most common form of hair loss in women. Many triggers have been identified, as stress, drugs, trauma, endocrine disease, nutritional deficiencies, and febrile states. We report three cases of TE occurred after severe Sars‐Cov‐2 infection and provide our clinical management, according to Sars‐Cov‐2 hygiene measures. Only one case report has been found in the literature associating anagen effluvium during severe Sars‐Cov‐2 infection. Other studies reported the exacerbation of a preexisting TE, correlated to the stress of lockdown. In our cases, patients never had a TE diagnosis before and did not report previous evident hair loss. TE can be associated with post severe Sars‐Cov‐2 infection. From our revision of the literature, this is the first case‐series describing TE in post severe Sars‐Cov‐2 patients. Further studies are needed to evaluate the relationship between TE and Sars‐Cov‐2 infection.

    Search related documents:
    Co phrase search for related documents
    • acute cause and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute cause and long hospitalization: 1
    • acute cause and lopinavir ritonavir: 1, 2, 3, 4, 5
    • acute onset and admission week: 1
    • acute onset and liver kidney: 1, 2, 3, 4, 5
    • acute onset and long hospitalization: 1, 2
    • acute onset and lopinavir ritonavir: 1, 2, 3
    • acute phase and admission week: 1, 2
    • acute phase and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute phase and lockdown stress: 1
    • acute phase and lopinavir ritonavir: 1, 2, 3, 4, 5